Joan Moser

Joan Moser has a diverse work experience spanning several decades. Joan currently holds the position of Director CMC Project Management at Scorpion Therapeutics since January 2023. Before this, from June 2022 to January 2023, they worked at Veranova as the Director of NPI Program Management & Operations Excellence.

Joan's longest tenure was at Johnson Matthey, where they served as the Director of ANDA Program Management from November 2013 to June 2022. In this role, they collaborated with the Product Selection team to develop strategies for a vertically integrated portfolio of generic products. Joan was also responsible for negotiating contracts, making CDMO placement decisions, and managing various agreements.

From 2001 to 2013, Joan worked at Teva Pharmaceuticals. Their roles included Associate Director of US R&D Portfolio, API Technical Specialist, Associate Manager of Technical Management, and Associate Manager of Regulatory Compliance. Their responsibilities included managing the generic R&D pipeline for the US market, coordinating activities between domestic and international development sites, performing audits, managing product recalls, and hosting regulatory agency inspections.

Prior to Teva Pharmaceuticals, Joan worked as a Senior Scientist at Betz Laboratories from 2000 to 2001. Joan also served as Vice President at The Moser Group from 1996 to 2000. Before that, they worked at Betz Laboratories as a Senior Scientist from 1992 to 1996.

Joan's early career includes a role as an Associate Process Chemist at W. R. Grace & Co. from 1989 to 1992, and as a Chemist at Pennwalt Corporation from 1985 to 1989.

Joan Moser attended Temple University from 1981 to 1985, where they earned a Bachelor of Arts degree in Chemistry.